Literature DB >> 18982079

Total thyroidectomy for medically refractory amiodarone-induced thyrotoxicosis.

Ankit N Mehta1, Raphaelle D Vallera, Chad R Tate, Rebecca A Sager, Brian J Welch.   

Abstract

Amiodarone is a class III antiarrhythmic drug widely used for both ventricular and supraventricular tachyarrhythmias. Due to its high iodine content and structural similarity to thyroxine, abnormalities in thyroid function are common in patients taking amiodarone, especially with long-term use. Both hypo- and hyperthyroidism have been associated with amiodarone, with the former far more common in the United States. We present a patient with medically refractory amiodarone-induced thyrotoxicosis after a 2-year history of amiodarone use, resulting in cardiac arrest and encephalopathy. The patient ultimately required total thyroidectomy for symptomatic control.

Entities:  

Year:  2008        PMID: 18982079      PMCID: PMC2566909          DOI: 10.1080/08998280.2008.11928432

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN: 0899-8280


  20 in total

Review 1.  The effects of amiodarone on the thyroid.

Authors:  E Martino; L Bartalena; F Bogazzi; L E Braverman
Journal:  Endocr Rev       Date:  2001-04       Impact factor: 19.871

2.  Amiodarone-induced hyperthyroidism: thyroidectomy under local anesthesia.

Authors:  A Mehra; J Widerhorn; J Lopresti; S H Rahimtoola
Journal:  Am Heart J       Date:  1991-10       Impact factor: 4.749

3.  Surgical management of amiodarone-associated thyrotoxicosis: too risky or too effective?

Authors:  E Hamoir; M Meurisse; T Defechereux; J Joris; J Vivario; G Hennen
Journal:  World J Surg       Date:  1998-06       Impact factor: 3.352

4.  Amiodarone and thyroid hormone metabolism.

Authors:  W M Wiersinga; M D Trip
Journal:  Postgrad Med J       Date:  1986-10       Impact factor: 2.401

5.  Lithium treatment in amiodarone-induced thyrotoxicosis.

Authors:  G Dickstein; C Shechner; F Adawi; J Kaplan; E Baron; S Ish-Shalom
Journal:  Am J Med       Date:  1997-05       Impact factor: 4.965

6.  Treatment of amiodarone-induced thyrotoxicosis, a difficult challenge: results of a prospective study.

Authors:  L Bartalena; S Brogioni; L Grasso; F Bogazzi; A Burelli; E Martino
Journal:  J Clin Endocrinol Metab       Date:  1996-08       Impact factor: 5.958

7.  Radioactive iodine thyroid uptake in patients with amiodarone-iodine-induced thyroid dysfunction.

Authors:  E Martino; L Bartalena; S Mariotti; F Aghini-Lombardi; C Ceccarelli; F Lippi; M Piga; A Loviselli; L Braverman; M Safran
Journal:  Acta Endocrinol (Copenh)       Date:  1988-10

8.  Severe hyperthyroidism requiring therapeutic plasmapheresis in a patient with hydatidiform mole.

Authors:  Yeşim Erbil; Deniz Tihan; Adil Azezli; Artur Salmaslioğlu; Yasemin Ozlük; Ahmet Büyükören; Selçuk Ozarmağan
Journal:  Gynecol Endocrinol       Date:  2006-07       Impact factor: 2.260

9.  Treatment of amiodarone-associated thyrotoxicosis.

Authors:  Jayne A Franklyn; Michael D Gammage
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2007-09

10.  Thyroidectomy for amiodarone-induced thyrotoxicosis.

Authors:  A P Farwell; S L Abend; S K Huang; N A Patwardhan; L E Braverman
Journal:  JAMA       Date:  1990-03-16       Impact factor: 56.272

View more
  1 in total

1.  Amiodarone-induced Thyrotoxicosis with Cardiopulmonary Arrest.

Authors:  Kosuke Inoue; Jun Saito; Tetsuo Kondo; Kaoru Miki; Chiho Sugisawa; Yuya Tsurutani; Naoki Hasegawa; Shinya Kowase; Yukio Kakuta; Masao Omura; Tetsuo Nishikawa
Journal:  Intern Med       Date:  2017-10-16       Impact factor: 1.271

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.